Myalgic Encephalomyelitis (ME) or What? An Operational Definition.
Twisk, Frank · Diagnostics (Basel, Switzerland) · 2018 · DOI
Quick Summary
This paper proposes a clear, practical definition of ME (myalgic encephalomyelitis) to help doctors reliably identify and study the condition. The authors argue that ME is a distinct multi-system illness characterized by severe muscle exhaustion after minimal activity, neurological symptoms (like brain fog and autonomic problems), and a pattern of symptom fluctuation and relapse over months or years. Having a precise definition is essential so researchers can study the right patients and develop effective treatments.
Why It Matters
Clear diagnostic criteria are fundamental to ME/CFS research—without them, studies may inadvertently enroll heterogeneous patient populations, making it impossible to develop targeted therapies. This paper addresses the critical problem that ME has been conflated with the broader, less-specific CFS label, potentially obscuring the disease's true biology and slowing therapeutic progress.
Observed Findings
ME typically has sudden onset often following respiratory or gastrointestinal infection
ME is distinguished by muscle fatigability and prolonged muscle weakness after trivial exertion
ME involves neurological disturbance affecting cognitive, autonomic, and sensory functions
ME is characterized by symptom fluctuation within and between episodes
ME follows a prolonged relapsing course with a tendency toward chronicity
Inferred Conclusions
ME is a distinct multi-systemic neuromuscular disease that should be discriminated from the broader CFS category
Four mandatory diagnostic elements should define ME operationally: post-exertional muscle weakness lasting days, neurological disturbance, symptom fluctuation, and relapsing course
Application of precise ME criteria is essential for future research to develop effective therapies
Remaining Questions
How should 'neurological disturbance' be operationalized and measured consistently across clinical settings?
Will prospective validation of these criteria against patient cohorts and controls confirm their diagnostic accuracy and specificity?
What This Study Does Not Prove
This is a definitional/conceptual paper, not a prospective clinical validation study, so it does not prove that the proposed criteria will reliably distinguish ME from other conditions in practice. The paper does not establish the biological mechanisms underlying ME, nor does it validate these criteria against biomarkers or imaging findings. It is a framework proposal rather than empirical evidence of diagnostic accuracy.